🇺🇸 FDA
Pipeline program

Oral levetiracetam

CHFudanU_NNICU3

Phase 2 small_molecule terminated

Quick answer

Oral levetiracetam for Neonatal Seizures is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Neonatal Seizures
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials